Related Experiment Video

Updated: Jun 28, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

Differential hypometabolism patterns according to mild cognitive impairment subtypes

Anne M Jauhiainen1, Tuija Kangasmaa, Minna Rusanen

  • 1Unit of Neurology, Institute of Clinical Medicine, Mediteknia, Kuopio, Finland.

Dementia and Geriatric Cognitive Disorders
|November 7, 2008
PubMed
Abstract

Insights

Subjects with Alzheimer's-type mild cognitive impairment (aMCI) show reduced brain glucose metabolism, especially in the medial temporal lobe. Functional changes appear more significant than structural atrophy in mild cognitive impairment (MCI).

Area of Science:

  • Neuroscience
  • Neurology
  • Medical Imaging

Background:

  • Mild cognitive impairment (MCI) represents a transitional stage between normal aging and dementia.
  • Distinguishing between Alzheimer's-type MCI (aMCI) and non-Alzheimer's-type MCI (naMCI) is crucial for prognosis and treatment.
  • Cerebral glucose metabolism and structural integrity are key indicators of neurodegeneration.

Purpose of the Study:

  • To investigate differences in cerebral glucose metabolism and structural atrophy between controls, aMCI, and naMCI.
  • To identify specific brain regions affected by metabolic and structural changes in MCI subtypes.
  • To compare the prominence of functional versus structural changes in MCI.

Main Methods:

  • Study included 13 controls, 7 aMCI, and 7 naMCI subjects.
  • Cerebral glucose metabolism assessed using Statistical Parametric Mapping 2 (SPM2).
  • Voxel-based morphometry in SPM2 used for whole-brain grey matter structural analysis.

Main Results:

  • aMCI subjects exhibited significant hypometabolism in the medial temporal lobe compared to controls and naMCI.
  • Both aMCI and naMCI groups showed posterior cingulate hypometabolism versus controls.
  • naMCI subjects displayed frontal and occipital atrophy, unlike aMCI subjects.

Conclusions:

  • aMCI is characterized by reduced glucose uptake in Alzheimer's-vulnerable regions, more so than in naMCI.
  • Functional brain changes (hypometabolism) may precede or be more pronounced than structural changes in MCI.
  • Findings aid in differentiating MCI subtypes and understanding disease progression.

More Related Videos

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.